Don't administer remdesivir with HCQS or CQ, FDA warns of drug interaction Dr. Kamal Kant Kohli16 Jun 2020 12:45 PM ISTThe U.S. Food and Drug Administration has issued warning to health care providers about a newly discovered potential drug interaction related to the...
CDSCO reviewing Cipla, Dr Reddys, others applications for Remdesivir on priority: Health Ministry Ruchika Sharma15 Jun 2020 4:00 PM ISTThe CDSCO is awaiting the data and is providing complete support to these companies. It has already waived off the requirement of local clinical...
Govt shows green flag to HCQ for early COVID cases, remdesivir for moderate stage Ruchika Sharma15 Jun 2020 3:39 PM ISTUnder emergency use authorization, remdesivir may be considered for patients in moderate stage requiring oxygen support.
Dr Reddy's, Gilead enter licensing pact for investigational COVID drug Remdesivir Ruchika Sharma15 Jun 2020 11:35 AM ISTDr. Reddy’s will receive technology transfer from Gilead for the manufacturing of this drug.
Combating COVID-19: India to soon begin domestic production of Remdesivir drug Farhat Nasim14 Jun 2020 10:15 AM IST"Pharma companies have been directed to conduct Active-Post Marketing Surveillance of each case and prepare a report on the benefit or recovery of a...
Remdesivir Does not Show Benefit In Mortality: AIIMS Director Medical Dialogues Bureau13 Jun 2020 12:45 PM ISTData suggests that it helps to decrease hospital stay but it doesn't show benefit as far as death or mortality benefit is concerned. So we need more...
DCGI nod to Gilead Sciences Remdesivir to treat COVID-19 cases in India Farhat Nasim3 Jun 2020 10:58 AM ISTRemdesivir has been allowed for restricted emergency use for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and...
Gilead's remdesivir shows modest improvement in moderate COVID-19 patients Dr. Kamal Kant Kohli2 Jun 2020 6:29 PM ISTGilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a...
CDSCO shows green flag to Gilead Sciences to market COVID-19 drug Remdesivir Ruchika Sharma2 Jun 2020 11:50 AM IST"The drug, which is administered in the form of an injection, has been approved to be sold by retail on the prescription of specialists for use in the...
Mylan partner AGP to sell COVID-19 drug Remdesivir soon: Bloomberg Ruchika Sharma1 Jun 2020 10:00 AM ISTIt has a similar arrangement for the Hepatitis C treatment Sovaldi, which will import from Mylan
Gilead Sciences seeks marketing authorisation from India for patented drug remdesivir Ruchika Sharma30 May 2020 2:00 PM ISTNew Delhi: A US pharmaceutical giant has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which...
Roche mixes Actemra with Gilead's remdesivir in new COVID-19 trial Ruchika Sharma30 May 2020 12:45 PM ISTZurich: Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better...
